Raumedic AG Restructures its Business Units

Over the last two years, Raumedic AG has invested a lot in the expansion and development of its locations in Europe and North America. The extension of the company headquarters in Helmbrechts, North Bavaria, an investment of 26 million Euro, was built including areas for the administration, laboratories and logistics as well as an area of 24,200 square feet (2,250 square meters) for Class 7 cleanroom production.
 
In January of this year, Mills River in North Carolina launched operations at Raumedic’s first American production facility. The costs for this investment are estimated at 27 million USD.
 
A polymer processor specializing in medical engineering and pharmaceuticals is expected to produce efficient and flexible structures. Especially when it comes to realizing customized products by means of extrusion, injection molding, and assembly, a quick response to the customer’s requirements is crucial. For this reason, Raumedic is establishing a new organization and structure. Less is more, now. The originally three business units will become two. Operations concerning extruded tubing will continue to be coordinated within the Tubing business unit, managed by Dr. Ralf Ziembinski. Injection molding components and their subsequent processing into modules and systems will be housed within the Systems business unit with immediate effect. Thomas Knechtel, who has been responsible for the assembly unit and the development of catheters previously, will now manage the new business unit Systems as a whole. This will help Raumedic to ensure that all expertise concerning the development and production of complex system products is centralized in one strong unit. The synergy effects resulting thereof will not only increase the efficiency when processing the request of customers. They will also guarantee that each customer is served instantly and directly. Next to the regional sales representative, a contact person will be available at Raumedic’s development center.
 
“This new structure guarantees that the technology, quality and service that we as a polymer specialist for the medical engineering and pharmaceutical industry offer, will also in future be highly qualified and quickly available for our customers and their product ideas,” remarked Martin Bayer, sole managing director of Raumedic AG.
 
These technologies include, among others things, micro and multi-component injection molding, insertion molding, fully automated assembly facilities, extrusion of tubing (also in the micro-range), and film blowing.
 
The raw materials employed in the production of these technologies include nearly all thermoplastics as well as silicone.
 
With this step, Raumedic AG is strengthening its market position as a full-service supplier for the realization of polymeric ideas—manufactured on 108,000 square feet (10,000 square meters) of cleanroom production area.